.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This double-blind, randomized, placebo-controlled trial assessed the effects of perioperative pregabalin on postoperative pain following laminectomy and instrumented fusion for degenerative lumbar spine disease. Fifty-four patients were randomized to receive 150 mg pregabalin, 300 mg pregabalin, or placebo before and after surgery. There was no significant difference in cumulative 48-hour morphine consumption among the groups. However, postoperative pain at 24 hours was significantly lower in both pregabalin groups compared with placebo: mean pain scores were 1.1 with 150 mg, 1.4 with 300 mg, and 3.1 with placebo (P=0.007). No significant differences were observed in opioid-related adverse effects. The study therefore suggests that perioperative pregabalin may provide an early postoperative analgesic benefit, although it did not reduce overall opioid consumption.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This double-blind, randomized, placebo-controlled trial assessed the effects of perioperative pregabalin on postoperative pain following laminectomy and instrumented fusion for degenerative lumbar spine disease. Fifty-four patients were randomized to receive 150 mg pregabalin, 300 mg pregabalin, or placebo before and after surgery. There was no significant difference in cumulative 48-hour morphine consumption among the groups. However, postoperative pain at 24 hours was significantly lower in both pregabalin groups compared with placebo: mean pain scores were 1.1 with 150 mg, 1.4 with 300 mg, and 3.1 with placebo (P=0.007). No significant differences were observed in opioid-related adverse effects. The study therefore suggests that perioperative pregabalin may provide an early postoperative analgesic benefit, although it did not reduce overall opioid consumption.
Today
A randomized trial shows oral DL-3-n-butylphthalide (200 mg thrice daily) significantly slows functional decline in spinocerebellar ataxia type 3 over 12 months, improving SARA and SCAFI scores with favorable safety and zero serious adverse events.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
Last week
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
Last week
